BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931]
URL: https://www.wjgnet.com/1007-9327/full/v26/i22/2931.htm
Number Citing Articles
1
Apichat Kaewdech, Pimsiri Sripongpun, Natcha Cheewasereechon, Sawangpong Jandee, Naichaya Chamroonkul, Teerha Piratvisuth. Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma PatientsClinical and Translational Gastroenterology 2021; 12(2): e00310 doi: 10.14309/ctg.0000000000000310
2
Sara Cuesta-Sancho, Mercedes Márquez-Coello, Francisco Illanes-Álvarez, Denisse Márquez-Ruiz, Ana Arizcorreta, Fátima Galán-Sánchez, Natalia Montiel, Manuel Rodriguez-Iglesias, José-Antonio Girón-González. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological responseWorld Journal of Hepatology 2022; 14(1): 62-79 doi: 10.4254/wjh.v14.i1.62
3
Cristina Maria Muzica, Carol Stanciu, Cristina Cijevschi-Prelipcean, Irina Girleanu, Laura Huiban, Oana Cristina Petrea, Ana-Maria Singeap, Camelia Cojocariu, Tudor Cuciureanu, Catalin Sfarti, Sebastian Zenovia, Stefan Chriac, Gabriela Stefanescu, Irina Ciortescu, Corina Lupașcu-Ursulescu, Egidia Miftode, Anca Trifan. Long-term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus InfectionHepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.115910
4
Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, Alessio Aghemo. Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?Viruses 2021; 13(6): 1048 doi: 10.3390/v13061048
5
Elias Kouroumalis, Argyro Voumvouraki. Hepatitis C virus: A critical approach to who really needs treatmentWorld Journal of Hepatology 2022; 14(1): 1-44 doi: 10.4254/wjh.v14.i1.1
6
Cristina Maria Marginean, Denisa  Pirscoveanu, Mihaela Popescu, Corina Maria Vasile, Anca Oana Docea, Radu Mitruț, Iulia Cristina Mărginean, George Alexandru Iacob, Dan Mihai Firu, Paul Mitruț. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current EvidenceBiomedicines 2023; 11(7): 1840 doi: 10.3390/biomedicines11071840
7
Sabine Gufler, Rita Seeboeck, Christoph Schatz, Johannes Haybaeck. The Translational Bridge between Inflammation and HepatocarcinogenesisCells 2022; 11(3): 533 doi: 10.3390/cells11030533
8
Nermine Magdi Riad, Heba Adel AbdEl Ghaffar, Reem Raied Mansour, Walaa Abdel Fattah, Ahmed Khairy, Ayman Yosry, Naglaa Ali Zayed, Mariam Onsy F. Hanna. Clinical Significance of Evaluation of Monocytic Receptors in Patients with Hepatitis C Virus InfectionViral Immunology 2023; 36(7): 475 doi: 10.1089/vim.2022.0180
9
Shinya Maekawa, Shinichi Takano, Nobuyuki Enomoto. Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatmentJournal of the Formosan Medical Association 2024; 123(11): 1124 doi: 10.1016/j.jfma.2024.01.015
10
A. Romano, N. Zeni, A. R. Caspanello, S. Phillips, S. S. Piano, P. Angeli. Follow‐up post‐HCV virological response to DAA in advanced chronic liver diseaseLiver International 2024;  doi: 10.1111/liv.16113